| 產品名稱 | 
      Human herpesvirus 3 | 
    
    
      | 商品貨號 | 
      B162902 | 
    
      
      | Classification | 
      Herpesviridae, Varicellovirus | 
    
      
      | Deposited As | 
      Varicella-Zoster | 
    
      
      | Agent | 
      Human herpesvirus 3 | 
    
      
      | Strain | 
      AV92-3:L (low passage) | 
    
      
      | Common Name | 
      Varicella zoster virus | 
    
      
      | Biosafety Level | 
      2 
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.   | 
    
      
      | Product Format | 
      frozen | 
    
      
      | Storage Conditions | 
      Vapor phase of liquid nitrogen | 
    
      
      | Comments | 
      Frozen infected cells and supernate  | 
    
      
      | Effect on Host | 
      CPE (slowly developing focal rounding and sloughing)  | 
    
      
      | Recommended Host | 
      BS-C-1 cells (ATCC® CCL-26™)  | 
    
      
      | Growth Conditions | 
      Incubation: 5-7 days at 37°C | 
    
      
      | Name of Depositor | 
      A Vafai | 
    
      
      | Special Collection | 
      NCRR Contract | 
    
      
      | Source | 
      Patient with zoster | 
    
      
      | References | 
      
            Vafai A. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein.  Vaccine 12: 1265-1269, 1994. PubMed: 7531921
          |